1. Chen T, Xu A, Lian J, Chu Y, Zhang H, Xu M. Transcolonic endoscopic appendectomy: a novel natural orifice transluminal endoscopic surgery (NOTES) technique for the sessile serrated lesions involving the appendiceal orifice. GUT 2021, 70(10): 1812-1814. 2. Chu Y, Xu M. A Real-World Promising Result of Endoscopic Full-Thickness Resection: It's Time for Endoscopic Full-Thickness Resection to Be Widely Used. AM J GASTROENTEROL 2020, 115(12): 1972-1973. 3. Ferreira Cardoso M, Cai MY, Xu MD. Endoscopic full‐thickness resection of a colonic schwannoma. DIGEST ENDOSC 2019, 31(3). 4. Zhang Y, Ding H, Chen T, Zhang X, Chen W, Li Q, Yao L, Korrapati P, Jin X, Zhang Y, Xu M, Zhou P. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort. CLIN GASTROENTEROL H 2019, 17(1): 73-81. 5. Chen H, Li B, Li L, Vachaparambil CT, Lamm V, Chu Y, Xu M, Cai Q. Current Status of Endoscopic Resection of Gastric Subepithelial Tumors. The American Journal of Gastroenterology 2019, 114(5): 718-725. 6. Chen T, Lin Z, Zhang Y, Chen W, Zhong Y, Wang Q, Yao L, Zhou P, Xu M. Submucosal Tunneling Endoscopic Resection vs Thoracoscopic Enucleation for Large Submucosal Tumors in the Esophagus and the Esophagogastric Junction. J AM COLL SURGEONS 2017, 225(6): 806-816. 7. Zhang Y, Chen T, Zhang C, Li Q, Chen W, Yao L, Zhou P, Xu M. Endoscopic Submucosal Dissection for Superficial Proximal Esophageal Neoplasia is Highly Successful. ANN SURG 2017, 266(6): 995-999. 8. Chen T, Zhou P, Chu Y, Zhang Y, Chen W, Ji Y, Yao L, Xu M. Long-term Outcomes of Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Submucosal Tumors. ANN SURG 2017, 265(2): 363-369. 9. Xu M, Cai Q. Editorial: Endoscopic Resection of Upper Gastrointestinal Subepithelial Tumors: Promising New Endoscopic Techniques—Are They Here to Stay? AM J GASTROENTEROL 2016, 111(6): 797-799. 10. Li Q, He M, Xu M. An Unusual Cause of Dysphagia and Melena. GASTROENTEROLOGY 2016, 151(4): e7-e8. 11. Li Q, Chen W, Zhang X, Cai M, Zhang Y, Hu J, He M, Yao L, Zhou P, Xu M. Submucosal Tunneling Endoscopic Septum Division: A Novel Technique for Treating Zenker's Diverticulum. GASTROENTEROLOGY 2016, 151(6): 1071-1074. 12. Chen T, Zhang C, Yao L, Zhou P, Zhong Y, Zhang Y, Chen W, Li Q, Cai M, Chu Y, Xu M. Management of the complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors. ENDOSCOPY 2016, 48(02): 149-155. 13. Xu M, Wang X, Zhou P, Li Q, Zhang Y, Zhong Y, Chen W, Ma L, Ishaq S, Qin W, Hu J, Yao L. Endoscopic full-thickness resection of colonic submucosal tumors originating from the muscularis propria: an evolving therapeutic strategy. ENDOSCOPY 2013, 45(09): 770-773. 14. Xu M, Cai M, Zhou P, Qin X, Zhong Y, Chen W, Hu J, Zhang Y, Ma L, Qin W, Yao L. Submucosal tunneling endoscopic resection: a new technique for treating upper GI submucosal tumors originating from the muscularis propria layer (with videos). GASTROINTEST ENDOSC 2012, 75(1): 195-199. 15.Chu Y, Chen T, Li H, Zhou P, Zhang Y, Chen W, Zhong Y, Yao L, Xu M. Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms. SURG ENDOSC 2019, 33(4): 1244-1251.

发表SCI论文30余篇，其中第一/通讯作者在Hepatology等消化病权威SCI期刊发表论文25篇 1. Zeng X, Lin Y, Yin C, Zhang X, Ning BF, Zhang Q, Zhang JP, Qiu L, Qin XR, Chen YX, Xie WF. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology. 2011 Dec;54(6):2036-47. doi: 10.1002/hep.24647. PMID: 21898499. 2. Zeng X, Shi ZW, Yu JJ, Wang LF, Luo YY, Jin SM, Zhang LY, Tan W, Shi PM, Yu H, Zhang CQ, Xie WF. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1948-1958. doi: 10.1002/jcsm.12797. Epub 2021 Sep 14. PMID: 34520115; PMCID: PMC8718091. 3. Zeng X, Zhang LY, Liu Q, Lu CH, Wei J, Shi ZW, Huang WR, Qu LH, Xu F, Wang XH, Shi PM, Tan Y, Tan W, Yuan ZL, Xia CY, Liu YL, Xie WF. Combined Scores from the EncephalApp Stroop Test, Number Connection Test B, and Serial Dotting Test Accurately Identify Patients With Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1618-1625.e7. doi: 10.1016/j.cgh.2019.11.018. Epub 2019 Nov 9. PMID: 31712074. 4. Zeng X, Sheng X, Wang PQ, Xin HG, Guo YB, Lin Y, Zhong JW, He CZ, Yin J, Liu TT, Ma WJ, Xiao X, Shi PM, Yuan ZL, Yang L, Ma X, Xu JM, Shen XZ, Yang CQ, Zhu X, Lv NH, Xie WF. Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis. Hepatol Int. 2021 Feb;15(1):155-165. doi: 10.1007/s12072-020-10117-y. Epub 2021 Jan 1. PMID: 33385299. 5. Zeng X, Li XX, Shi PM, Zhang YY, Song Y, Liu Q, Wei L, Bajaj JS, Zhu YH, Li Y, Gu Y, Xie WF, Liu YL. Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients. J Gastroenterol Hepatol. 2019 Oct;34(10):1843-1850. doi: 10.1111/jgh.14656. Epub 2019 Apr 7. PMID: 30861191. 6. Zeng X, Tang XJ, Sheng X, Ni W, Xin HG, Chen WZ, Jiang CF, Lin Y, Shi J, Shi B, Chen YX, Yuan ZL, Xie WF. Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study. J Dig Dis. 2015 Nov;16(11):665-74. doi: 10.1111/1751-2980.12294. PMID: 26474237. 7. Luo YY, Tao KG, Lu YT, Li BB, Wu KM, Ding CH, Yan FZ, Liu Y, Lin Y, Zhang X, Zeng X. Hsa_Circ_0098181 Suppresses Hepatocellular Carcinoma by Sponging miR-18a-3p and Targeting PPARA. Front Pharmacol. 2022 Feb 21;13:819735. doi: 10.3389/fphar.2022.819735.（通讯作者） 8. Feng LM, Wang PQ, Yu H, Chen RT, Wang J, Sheng X, Yuan ZL, Shi PM, Xie WF, Zeng X. New formula for predicting standard liver volume in Chinese adults. World J Gastroenterol. 2017 Jul 21;23(27):4968-4977. doi: 10.3748/wjg.v23.i27.4968. PMID: 28785151; PMCID: PMC5526767.（通讯作者） 9. Li X, Xu W, Shi J, Lin Y, Zeng X. Endoscopic ultrasound elastography for differentiating between pancreatic adenocarcinoma and inflammatory masses: a meta-analysis. World J Gastroenterol. 2013 Oct 7;19(37):6284-91. doi: 10.3748/wjg.v19.i37.6284. PMID: 24115828; PMCID: PMC3787361. （通讯作者） 10. Xu W, Shi J, Li X, Zeng X, Lin Y. Endoscopic ultrasound elastography for differentiation of benign and malignant pancreatic masses: a systemic review and meta-analysis. Eur J Gastroenterol Hepatol. 2013 Feb;25(2):218-24. doi: 10.1097/MEG.0b013e32835a7f7c. PMID: 23169307. （通讯作者） 11. Hu PF, Zeng X, Zou ZY, Tang W, Guo YB, Yuan ZL, Shi PM, Tan Y, Song Y, Shi YQ, Xie WF. The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study. Hepatobiliary Surg Nutr. 2021 Dec;10(6):811-824. doi: 10.21037/hbsn-20-263. PMID: 35004947; PMCID: PMC8683915. （共同第一作者） 12. Feng LM, Lei SJ, Zeng X, Wang PQ, Chen RT, Wang J, Sheng X, Shi PM, Yuan ZL, Xie WF. The evaluation of non-invasive multi-slice spiral computed tomography-based indices for the diagnosis and prognosis prediction of liver cirrhosis. J Dig Dis. 2017 Aug;18(8):472-479. doi: 10.1111/1751-2980.12506. PMID: 28671764. （共同第一作者） 13. Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C, Shi J, Lu C, Ning B, Zhang J, Lin Y. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Liver Int. 2015 Apr;35(4):1234-43. doi: 10.1111/liv.12660. Epub 2014 Sep 15. PMID: 25142507. （共同第一作者） 14. Song CY, Zeng X, Wang Y, Shi J, Qian H, Zhang Y, Fang JQ, Sheng X, Zheng JM, Chen YX. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis. J Gastroenterol Hepatol. 2015 Feb;30(2):405-12. doi: 10.1111/jgh.12691. PMID: 25089018. （共同第一作者） 15. Song CY, Zeng X, Chen SW, Hu PF, Zheng ZW, Ning BF, Shi J, Xie WF, Chen YX. Sophocarpine alleviates non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol. 2011 Apr;26(4):765-74. doi: 10.1111/j.1440-1746.2010.06561.x. PMID: 21054517. （共同第一作者） 16. Yang XJ, Lin Y, Zeng X, Shi J, Chen YX, Shen JW, Xie WF. A minimally invasive alternative for managing large pancreatic duct stones using a modified expandable metal mesh stent. Pancreatology. 2009;9(1-2):111-5. doi: 10.1159/000178881. Epub 2008 Dec 12. PMID: 19077461. （共同第一作者） 17. Xu W, Shi J, Zeng X, Li X, Xie WF, Guo J, Lin Y. EUS elastography for the differentiation of benign and malignant lymph nodes: a meta-analysis. Gastrointest Endosc. 2011 Nov;74(5):1001-9; quiz 1115.e1-4. doi: 10.1016/j.gie.2011.07.026. PMID: 22032315. （共同第一作者） 18. Hao Z, Tao K, Wu K, Luo Y, Lu Y, Li B, Shi P, Wang P, Zeng X, Lin Y. Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis. Hepatol Int. 2021 Jul 27. doi: 10.1007/s12072-021-10231-5. Epub ahead of print. PMID: 34313944. （共同通讯作者） 19. Xu F, Yu S, Han J, Zong M, Tan Q, Zeng X, Fan L. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer. Clin Transl Gastroenterol. 2021 Aug 12;12(8):e00386. doi: 10.14309/ctg.0000000000000386. PMID: 34382948; PMCID: PMC8367071. （共同通讯作者） 20. Sun QJ, Cai LY, Jian J, Cui YL, Huang CK, Liu SQ, Lu JL, Wang W, Zeng X, Zhong L. The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice. Front Pharmacol. 2021 Feb 2;11:605967. doi: 10.3389/fphar.2020.605967. PMID: 33603666; PMCID: PMC7884862. （共同通讯作者） 21. Song ST, Shi J, Wang XH, Guo YB, Hu PF, Zhu F, Zeng X, Xie WF. Prevalence and risk factors for gallstone disease: A population-based cross-sectional study. J Dig Dis. 2020 Apr;21(4):237-245. doi: 10.1111/1751-2980.12857. Epub 2020 Apr 15. PMID: 32166900. （共同通讯作者） 22. Wu K, Ye C, Lin L, Chu Y, Ji M, Dai W, Zeng X, Lin Y. Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT. Clin Sci (Lond). 2016 Aug 1;130(16):1469-80. doi: 10.1042/CS20160334. Epub 2016 May 25. PMID: 27226339. （共同通讯作者） 23. Zhu C, Ji M, Dai W, Ye C, Hu Z, Shi J, Zeng X, Lin Y. Clinicopathological characteristics of chinese colorectal cancer patients under 30 years of age: implication in diagnosis and therapy. Curr Cancer Drug Targets. 2015;15(1):27-34. doi: 10.2174/1568009615666150101115800. PMID: 25552365. （共同通讯作者） 24. Zhao J, Tang N, Wu K, Dai W, Ye C, Shi J, Zhang J, Ning B, Zeng X, Lin Y. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS One. 2014 Oct 10;9(10):e108005. doi: 10.1371/journal.pone.0108005. PMID: 25303175; PMCID: PMC4193742. （共同通讯作者） 25. Chen J, Shi J, Xie WF, Zeng X, Lin Y. Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients. Int J Infect Dis. 2012 Oct;16(10):e748-52. doi: 10.1016/j.ijid.2012.06.002. Epub 2012 Jul 25. PMID: 22836046. （共同通讯作者）

发表文章10余篇，其中SCI6篇

发表文章10余篇，其中SCI文章2篇，参编论著5本

近5年发表核心期刊论文5篇，SCI论文1篇

(1) LIMEI SHAO; YANBING LIU; Activating metabotropic glutamate receptor-7 attenuates visceral hypersensitivity in neonatal maternally separated rats, International Journal of Molecular Medici ne, 2019, 43(2): 761-770 (2) 刘雁冰; 辣椒素受体TRPV1在大鼠内脏高敏感性发病机制中的作用, 临床和实验医学杂志, 2016,15(10): 936-939  (3) 刘雁冰; 胶囊内镜在325例疑似小肠疾病中的诊断价值, 疑难病杂志, 2016.15(10): 1032-1035

以第一作者发表SCI数篇，中文核心期刊数篇。